Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Royal Bank of Canada

Royal Bank of Canada lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 17.0% in the fourth quarter, Holdings Channel reports. The firm owned 1,049,013 shares of the company’s stock after selling 215,247 shares during the quarter. Royal Bank of Canada’s holdings in Henry Schein were worth $72,591,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Olstein Capital Management L.P. boosted its stake in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after purchasing an additional 16,000 shares during the period. Private Management Group Inc. boosted its stake in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. acquired a new stake in shares of Henry Schein in the 4th quarter worth $417,000. Savant Capital LLC lifted its stake in shares of Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock worth $322,000 after acquiring an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock worth $1,113,000 after acquiring an additional 3,650 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on HSIC. Wells Fargo & Company reduced their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Finally, Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Insiders Place Their Bets

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Henry Schein Stock Up 1.8%

Shares of NASDAQ HSIC opened at $73.13 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The firm has a 50-day moving average price of $67.44 and a 200 day moving average price of $71.49. The stock has a market capitalization of $8.90 billion, a price-to-earnings ratio of 30.09, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the firm posted $1.10 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.